| Fugitive businessman taken into US custody in Venezuela bribery case |
AP Online |
10/11 |
20:32 |
| ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Unicycive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - UNCY |
Globe Newswire |
10/11 |
19:27 |
| AARD DEADLINE NOTICE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Aardvark Therapeutics, Inc. Investors to Secure Counsel Before Important October 13 Deadline in Securities Class Action – AARD |
Globe Newswire |
10/11 |
19:00 |
| ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages FuelCell Energy, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FCEL |
Globe Newswire |
10/11 |
18:06 |
| New Crypto: Remittix Confirms November 24 RTX Launch as Ethereum Price Prediction Eyes $12,000 and Cardano’s Tokenized-Equity Push Revives the $1 ADA Dream |
Globe Newswire |
10/11 |
17:30 |
| Six senators call for Trump administration to 'immediately reverse course' on Russian diesel plan |
AP Online |
10/11 |
17:15 |
| INVESTOR ALERT: Webull Corporation Investors with Substantial Losses May Seek to Lead Class Action Lawsuit Before December 7, 2026 Deadline, Robbins Geller Rudman & Dowd LLP Announces - BULL |
Globe Newswire |
10/11 |
17:10 |
| Bronstein, Gewirtz & Grossman LLC Urges Netcapital Inc. Investors to Act: Class Action Filed Alleging Investor Harm |
Globe Newswire |
10/11 |
17:03 |
| France's far-left presidential candidate cheers Gen Z school protests |
AP Online |
10/11 |
15:10 |
| Acoramidis Associated with Significantly Improved Clinical Outcomes Versus Tafamidis in ATTR-CM in an Independent, Real-World Study of U.S. Electronic Health Records |
Globe Newswire |
10/11 |
14:30 |
| Bronstein, Gewirtz & Grossman LLC Urges Coastal Financial Corporation Investors to Act: Class Action Filed Alleging Investor Harm |
Globe Newswire |
10/11 |
14:00 |
| Freenome to Present New Validation Data for Next-Generation CRC Screening Test in Late-Breaking Oral Presentation at ACG 2026 |
Globe Newswire |
10/11 |
13:00 |
| Crypto News: Remittix Opens PayFi to 1,000 Holders as Bitcoin Price Prediction Explodes to $200,000 and Solana’s 200ms Upgrade Fuels a $300 SOL Target |
Globe Newswire |
10/11 |
13:00 |
| ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Anavex Life Sciences Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – AVXL |
Globe Newswire |
10/11 |
12:39 |
| Bronstein, Gewirtz & Grossman LLC Urges Beta Bionics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm |
Globe Newswire |
10/11 |
12:00 |
| Bronstein, Gewirtz & Grossman LLC Urges Hyliion Holdings Corp. Investors to Act: Class Action Filed Alleging Investor Harm |
Globe Newswire |
10/11 |
12:00 |
| Bronstein, Gewirtz & Grossman LLC Urges XTI Aerospace, Inc. Investors to Act: Class Action Filed Alleging Investor Harm |
Globe Newswire |
10/11 |
12:00 |
| Bronstein, Gewirtz & Grossman LLC Urges Honeywell Aerospace, Inc. Investors to Act: Class Action Filed Alleging Investor Harm |
Globe Newswire |
10/11 |
12:00 |
| Bronstein, Gewirtz & Grossman LLC Urges HDFC Bank Limited Investors to Act: Class Action Filed Alleging Investor Harm |
Globe Newswire |
10/11 |
12:00 |
| Bronstein, Gewirtz & Grossman LLC Urges FuelCell Energy, Inc. Investors to Act: Class Action Filed Alleging Investor Harm |
Globe Newswire |
10/11 |
12:00 |
| Bronstein, Gewirtz & Grossman LLC Urges AEVEX Corp. Investors to Act: Class Action Filed Alleging Investor Harm |
Globe Newswire |
10/11 |
12:00 |
| Bronstein, Gewirtz & Grossman LLC Urges AST SpaceMobile, Inc. Investors to Act: Class Action Filed Alleging Investor Harm |
Globe Newswire |
10/11 |
12:00 |
| ROSEN, NATIONAL INVESTOR COUNSEL, Encourages AST SpaceMobile, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ASTS |
Globe Newswire |
10/11 |
11:46 |
| Encaleret Increased Bone Turnover and Improved Participant-Reported Symptoms in the Phase 3 CALIBRATE Trial in ADH1 |
Globe Newswire |
10/11 |
11:42 |
| Cardurion Pharmaceuticals Presents Phase 2 Results for Tovinontrine (CRD-750), a PDE9 Inhibitor, as a Novel Treatment for Heart Failure |
Globe Newswire |
10/11 |
11:35 |
